Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Yuh SAKATA"'
Autor:
Hiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa, Kohei Shitara, Yu Sunakawa, Koji Oba, Wasaburo Koizumi, Yuh Sakata, Hiroshi Furukawa, Yasuhide Yamada, Masahiro Takeuchi, Masashi Fujii
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Individual‐level surrogates are important for management in patients treated for advanced gastric cancer (AGC). This study aimed to comprehensively investigate the correlation of multiple clinical endpoints in the first‐line c
Externí odkaz:
https://doaj.org/article/5d737d0a98a74cc1afd8f1494ebe7875
Autor:
Naoya Sakamoto, Michio Nakamura, Isao Yokota, Yoshito Komatsu, Yasuyuki Kawamoto, Satoshi Yuki, Yasuo Takahashi, Yasushi Tsuji, Atsushi Sato, Shintaro Nakano, Kazuaki Harada, Takuto Miyagishima, Susumu Sogabe, Masayoshi Dazai, Atsushi Ishiguro, Shinya Kajiura, Miki Tateyama, Kazuteru Hatanaka, Takahide Sasaki, Yoshiaki Shindo, Tomoe Kobayashi, Yuh Sakata
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Introduction Combination chemotherapy with oxaliplatin, irinotecan, fluorouracil and leucovorin (FOLFIRINOX) has become one of the standard treatments for metastatic pancreatic cancer. However, the use of FOLFIRINOX requires prolonged infusion. There
Externí odkaz:
https://doaj.org/article/f88cfa70938b4b4aaef5a45e37270992
Autor:
Yasuyuki Kawamoto, Yoshito Komatsu, Satoshi Yuki, Kentaro Sawada, Tetsuhito Muranaka, Kazuaki Harada, Hiroshi Nakatsumi, Hiraku Fukushima, Atsushi Ishiguro, Masayoshi Dazai, Kazuteru Hatanaka, Michio Nakamura, Ichiro Iwanaga, Minoru Uebayashi, Susumu Sogabe, Yoshimitsu Kobayashi, Takuto Miyagishima, Kota Ono, Naoya Sakamoto, Yuh Sakata
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background In Japan, S-1 plus cisplatin (SP) regimen has become a standard therapy for patients with advanced gastric cancer. Moreover, the S-1 plus oxaliplatin regimen is now a standard treatment. Nab-paclitaxel was developed for chemothera
Externí odkaz:
https://doaj.org/article/5eb50e1555324189bdb9aa9a907bc4f0
Autor:
Hideyuki Ishida, Tatsuro Yamaguchi, Kohji Tanakaya, Kiwamu Akagi, Yasuhiro Inoue, Kensuke Kumamoto, Hideki Shimodaira, Shigeki Sekine, Toshiaki Tanaka, Akiko Chino, Naohiro Tomita, Takeshi Nakajima, Hirotoshi Hasegawa, Takao Hinoi, Akira Hirasawa, Yasuyuki Miyakura, Yoshie Murakami, Kei Muro, Yoichi Ajioka, Yojiro Hashiguchi, Yoshinori Ito, Yutaka Saito, Tetsuya Hamaguchi, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Hiroshi Kawano, Yusuke Kinugasa, Norihiro Kokudo, Keiko Murofushi, Takako Nakajima, Shiro Oka, Yoshiharu Sakai, Akihiko Tsuji, Keisuke Uehara, Hideki Ueno, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Michio Itabashi, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Yasuhiro Shimada, Keiichi Takahashi, Shinji Tanaka, Osamu Tsuruta, Toshiharu Yamaguchi, Kenichi Sugihara, Toshiaki Watanabe, Japanese Society for Cancer of the Colon and Rectum
Publikováno v:
Journal of the Anus, Rectum and Colon, Vol 2, Iss Suppl.I, Pp S1-S51 (2018)
Hereditary colorectal cancer accounts for less than 5% of all colorectal cancer cases. Some of the unique characteristics that are commonly encountered in cases of hereditary colorectal cancer include early age at onset, synchronous/metachronous occu
Externí odkaz:
https://doaj.org/article/8a3c0e6ce75f4e2eb6c69f83fcbf75e3
Autor:
Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Michio Nakamura, Osamu Muto, Susumu Sogabe, Yoshiaki Shindo, Atsushi Ishiguro, Atsushi Sato, Yasushi Tsuji, Masayoshi Dazai, Hiroyuki Okuda, Takashi Meguro, Kazuaki Harada, Mari Sekiguchi, Kazufumi Okada, Yoichi M Ito, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
The Oncologist. 27(8):e642-e649
Background Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cc69eba2d426282aed725eb5ff31f5
http://hdl.handle.net/2115/86546
http://hdl.handle.net/2115/86546
Autor:
Ken Ito, Satoshi Yuki, Hiroshi Nakatsumi, Yasuyuki Kawamoto, Kazuaki Harada, Shintaro Nakano, Rika Saito, Takayuki Ando, Kentaro Sawada, Masataka Yagisawa, Atsushi Ishiguro, Masayoshi Dazai, Ichiro Iwanaga, Kazuteru Hatanaka, Atsushi Sato, Ryusuke Matsumoto, Yoshiaki Shindo, Miki Tateyama, Tetsuhito Muranaka, Masaki Katagiri, Isao Yokota, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
Supportive Care in Cancer. 30(6):5351-5359
Purpose Dysgeusia is an adverse event caused by chemotherapy. Although retrospective studies have shown zinc administration improves dysgeusia, there have been no prospective studies. The present study examined effects of zinc therapy on dysgeusia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261c2ba1015e946b80516fcaac246c93
http://hdl.handle.net/2115/85674
http://hdl.handle.net/2115/85674
Autor:
Kazuaki Harada, Takahiro Yamamura, Osamu Muto, Michio Nakamura, Susumu Sogabe, Kentaro Sawada, Shintaro Nakano, Masataka Yagisawa, Tetsuhito Muranaka, Masayoshi Dazai, Miki Tateyama, Yoshimitsu Kobayashi, Sosuke Kato, Kazuteru Hatanaka, Yasuyuki Kawamoto, Satoshi Yuki, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 4
Pages: 1596
Volume 12
Issue 4
Pages: 1596
The effects of UGT1A1 gene polymorphisms or prior irinotecan treatment on treatment outcomes of nanoliposomal-irinotecan plus 5-fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with unresectable pancreatic ductal adenocarcinoma (PDAC) are not es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58106ec075031a2c6524330ed102f519
Autor:
Naruhito Takenaka, Yasuhiro Shimada, Hideo Baba, Yuh Sakata, Taroh Satoh, Yasuhide Yamada, Kenichi Sugihara, Masahiro Goto, Satoshi Morita, Kei Muro, Hideyuki Mishima, Masahiko Watanabe, Yoshito Komatsu, Tadashi Hirooka, Keiichi Takahashi
Publikováno v:
Glob Health Med
Mechanisms accounting for sex differences in the incidence of adverse events caused by fluoropyrimidine treatments, and histologic differences in efficacy are insufficiently understood. We determined differences between the sexes in terms of the safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dae93fa2786f664a1b3318541c42013
https://doi.org/10.35772/ghm.2020.01050
https://doi.org/10.35772/ghm.2020.01050
Autor:
Masayoshi Dazai, Yuh Sakata, Kazuaki Harada, Isao Yokota, Ichiro Iwanaga, Hiroshi Nakatsumi, Masataka Yagisawa, Kentaro Sawada, Takayuki Ando, Ryusuke Matsumoto, R. Saito, Yasuyuki Kawamoto, Kazuteru Hatanaka, Miki Tateyama, M. Katagiri, Satoshi Yuki, Atsushi Sato, Yoshiaki Shindo, Tetsuhito Muranaka, Atsushi Ishiguro, Yoshito Komatsu, Ken Ito, Shintaro Nakano, Naoya Sakamoto
PurposeDysgeusia is an adverse event caused by chemotherapy. Although retrospective studies have shown zinc administration improves dysgeusia, there have been no prospective studies. The present study examined effects of zinc therapy on dysgeusia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c05628bffe9e3d0858060c0692b9efa3
https://doi.org/10.21203/rs.3.rs-1028179/v1
https://doi.org/10.21203/rs.3.rs-1028179/v1
Autor:
Tatsuya Yokoyama, Ken Ito, Satoshi Yuki, Hiroshi Nakatsumi, Takayuki Ando, Kentaro Sawada, Masataka Yagisawa, Atsushi Ishiguro, Masayoshi Dazai, Ichiro Iwanaga, Kazuteru Hatanaka, Atsushi Sato, Ryusuke Matsumoto, Yoshiaki Shindo, Miki Tateyama, Tetsuhito Muranaka, Masaki Katagiri, Isao Yokota, Yuh Sakata, Yoshito Komatsu
Publikováno v:
Annals of Oncology. 33:S477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d521df7fcbdeebdfc60d0a2a4dd8228
https://doi.org/10.1016/j.annonc.2022.05.050
https://doi.org/10.1016/j.annonc.2022.05.050